Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1) (N-Term) Peptide

MAD1L1 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN5513399
$160.46
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 11 to 17 Business Days

Quick Overview for MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1) (N-Term) Peptide (ABIN5513399)

Target

MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))

Origin

Human

Source

  • 1
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Sequence

    HLIQVEREKM QMELSHKRAR VELERAASTS ARNYEREVDR NQELLTRIRQ

    Characteristics

    This is a synthetic peptide designed for use in combination with anti- MAD1L1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))

    Background

    MAD1L1 is a component of the mitotic spindle-assembly checkpoint that prevents the onset of anaphase until all chromosome are properly aligned at the metaphase plate. MAD1L1 functions as a homodimer and interacts with MAD2L1. MAD1L1 may play a role in cell cycle control and tumor suppression. Alternative splicing results in multiple transcript variants.

    Alias Symbols: MAD1, PIG9, TP53I9, TXBP181

    Protein Size: 718

    Gene ID

    8379

    NCBI Accession

    NM_001013836, NP_001013858

    UniProt

    Q9Y6D9
You are here:
Chat with us!